Prognostic impact of circulating HER2 extracellular domain (ECD) in women with metastatic breast cancer.

被引:0
|
作者
Zheng, Yabing [1 ]
Shao, Xiying [1 ]
Wang, Xiaojia [1 ]
Shi, Lei [1 ]
Huang, Yuan [1 ]
机构
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e22038
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Serial measurement of serum extracellular domain of HER2 (ECD/HER2) has prognostic value in metastatic breast cancer.
    Bramwell, V. H. C.
    Doig, G. S.
    Tuck, A. B.
    Wilson, S. M.
    Tonkin, K. S.
    Tomiak, A.
    Perera, F.
    Vandenberg, T. A.
    Chambers, A. F.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S40 - S40
  • [2] Circulating HER2 extracellular domain (ECD) predicts a poor prognosis for metastatic breast cancer patients
    Wang, X-J
    Shao, X-Y
    Xu, X-H
    Chen, Z-H
    Wang, S.
    Cai, J-F
    Huang, J.
    Huang, P.
    Lou, C-J
    Ling, Z-Q
    Han, M. X.
    CANCER RESEARCH, 2012, 72
  • [3] Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer
    Vivien H. C. Bramwell
    Gordon S. Doig
    Alan B. Tuck
    Sylvia M. Wilson
    Katia S. Tonkin
    Anna Tomiak
    Francisco Perera
    Theodore A. Vandenberg
    Ann F. Chambers
    Breast Cancer Research and Treatment, 2009, 114
  • [4] Changes over time of extracellular domain of HER2 (ECD/HER2) serum levels have prognostic value in metastatic breast cancer
    Bramwell, Vivien H. C.
    Doig, Gordon S.
    Tuck, Alan B.
    Wilson, Sylvia M.
    Tonkin, Katia S.
    Tomiak, Anna
    Perera, Francisco
    Vandenberg, Theodore A.
    Chambers, Ann F.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 503 - 511
  • [5] Circulating HER2 extracellular domain (ECD) levels are associated with progression-free survival in metastatic breast cancer patients
    Wang, X-J
    Shao, X-Y
    Chen, Z-H
    Ye, W-W
    Qin, J.
    Zhang, Y- M.
    Zheng, Y-B
    Yu, X-Y
    Lei, L.
    Ling, Z-Q
    Feng, J-G
    Han, M. X.
    CANCER RESEARCH, 2012, 72
  • [6] Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer
    Aurilio, Gaetano
    Sandri, Maria Teresa
    Pruneri, Giancarlo
    Zorzino, Laura
    Botteri, Edoardo
    Munzone, Elisabetta
    Adamoli, Laura
    Facchi, Giuseppina
    Cullura, Daniela
    Verri, Elena
    Rocca, Maria Cossu
    Zurrida, Stefano
    Iacovelli, Roberto
    Nole, Franco
    FUTURE ONCOLOGY, 2016, 12 (17) : 2001 - 2008
  • [7] Correlation between serum HER2 extracellular domain (HER2 ECD) levels and tumour size in early, advanced and metastatic breast cancer with HER2 overexpression
    Makino, H.
    Tengan, H.
    Tatsuda, K.
    Hashidate, H.
    Mio, K.
    Kiguchi, T.
    Yamazaki, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S114 - S115
  • [8] Prognostic and Predictive Impact of the HER-2/neu Extracellular Domain (ECD) in the Serum of Patients Treated with Chemotherapy for Metastatic Breast Cancer
    Volkmar Müller
    Isabell Witzel
    Hans Joachim Lück
    Günter Köhler
    Gunther von Minckwitz
    Volker Möbus
    Daniel Sattler
    Waldemar Wilczak
    Thomas Löning
    Fritz Jänicke
    Klaus Pantel
    Christoph Thomssen
    Breast Cancer Research and Treatment, 2004, 86 : 9 - 18
  • [9] Prognostic and predictive impact of the HER-2/neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer
    Müller, V
    Witzel, I
    Lück, HJ
    Köhler, G
    von Minckwitz, G
    Möbus, V
    Sattler, D
    Wilczak, W
    Löning, T
    Jänicke, F
    Pantel, K
    Thomssen, C
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 86 (01) : 9 - 18
  • [10] Characterization of serum HER2 extracellular domain (ECD) level in patients with metastatic colorectal cancer
    Hasegawa, Hiroko
    Taniguchi, Hiroya
    Masuishi, Toshiki
    Narita, Yukiya
    Komori, Azusa
    Nomura, Motoo
    Kadowaki, Shigenori
    Andoh, Masashi
    Ura, Takashi
    Muro, Kei
    ANNALS OF ONCOLOGY, 2015, 26 : 116 - 116